Evergreen Capital Management’s Genmab GMAB Stock Holding History

Evergreen Capital Management’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$591K	Buy	21,529 +750	+4%	+$19.9K	0.01%	809
2026 Q1	$558K	Sell	20,779 -1,571	-7%	-$47.1K	0.01%	723
2025 Q4	$688K	Buy	22,350 +2,752	+14%	+$85.8K	0.02%	581
2025 Q3	$601K	Buy	19,598 +9,901	+102%	+$241K	0.01%	578
2025 Q2	$200K	Buy	+9,697	New	+$199K	0.01%	1047
2025 Q1	–	Sell	-12,780	Closed	-$267K	–	1127
2024 Q4	$267K	Buy	+12,780	New	+$281K	0.01%	802
2023 Q4	–	Sell	-7,420	Closed	-$262K	–	867
2023 Q3	$262K	Buy	7,420 +1,310	+21%	+$49.9K	0.01%	606
2023 Q2	$232K	Buy	+6,110	New	+$244K	0.01%	660
2023 Q1	–	Sell	-7,160	Closed	-$303K	–	735
2022 Q4	$303K	Buy	+7,160	New	+$295K	0.01%	481

Other funds holding GMAB

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Evergreen Capital Management's GMAB Position: Q2 2026 in Review

Evergreen Capital Management increased its Genmab (GMAB) stake by 3.6% in Q2 2026, buying an estimated $19.9K and bringing the position to 21,529 shares worth $591K. The position accounts for 0.01% of the portfolio, ranked #809.

Evergreen Capital Management first reported a position in GMAB in Q4 2022 and has held it in 9 quarters since. The position peaked at $688K in Q4 2025. 290 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

Evergreen Capital Management held 21,529 shares of Genmab worth $591K as of Q2 2026.
Evergreen Capital Management bought 750 Genmab shares in Q2 2026, an estimated $19.9K.
Genmab made up 0.01% of Evergreen Capital Management's portfolio in Q2 2026, its #809 holding.
Evergreen Capital Management first reported a position in Genmab in Q4 2022 and has held it in 9 quarters since.
Evergreen Capital Management's Genmab position peaked at $688K in Q4 2025.
290 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Evergreen Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.